Brady James Aloysius insider trades
Brady James Aloysius has filed 9 Form 4s with the SEC that we hold, for VRNA (Director) and Xeris Biopharma Holdings, Inc. (XERS) (Director). Across all of them we count 0 purchases worth $0 and 2 sales worth $70.8K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($60.0K). The largest single trade was a sale of 10,834 shares of Xeris Biopharma Holdings, Inc. worth $60.0K, dated 2026-03-30. The first filing on our record is dated 2022-03-16 and the latest 2026-06-05.
VRNA
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-08-01 | S, sale reported on Form 4 | 824 | $10.8K | 2025-08-05 |
Xeris Biopharma Holdings, Inc. (XERS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-03-30 | S, sale reported on Form 4 | 10,834 | $60.0K | 2026-04-01 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1916987) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms